Tissue Heart Valves Global Market Report 2025

Description

Tissue heart valves are biological heart valves used in replacement surgeries, designed to function such as natural heart valves as an alternative to mechanical ones.

The primary types of tissue heart valves are stented and stentless valves. Stented tissue heart valves are bioprosthetic valves reinforced with a metal or polymer frame (stent) to provide structural support and simplify implantation during valve replacement procedures. These valves come in various types, including aortic, mitral, tricuspid, and pulmonary valves. They are utilized by multiple end-users, such as hospitals, ambulatory surgical centers, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tissue heart valves market research report is one of a series of new reports from The Business Research Company that provides tissue heart valves market statistics, including the tissue heart valves industry global market size, regional shares, competitors with the tissue heart valves market share, detailed tissue heart valves market segments, market trends, and opportunities, and any further data you may need to thrive in the tissue heart valves industry. This tissue heart valves market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue heart valves market size has grown steadily in recent years. It will grow from $1.48 billion in 2024 to $1.52 billion in 2025 at a compound annual growth rate (CAGR) of 2.3%. The growth in the historic period can be attributed to the growing prevalence of lifestyle diseases, rising healthcare expenditure, increasing elderly population, increase in cardiac & pathological disorders, and growing incidences of heart diseases.

The tissue heart valves market size is expected to see steady growth in the next few years. It will grow to $1.68 billion in 2029 at a compound annual growth rate (CAGR) of 2.6%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, the rise in popularity of sutureless procedures, the growing aging population, the growing demand for cardiovascular treatments, and increasing healthcare investments. Major trends in the forecast period include technological innovations, innovative culture systems, advancements in imaging technologies, advancements in surgical techniques, and expansion in emerging market.

The forecast of 2.6% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for bovine pericardial tissue and stent mounting components, sourced from key regions such as Australia and Brazil, could lead to shortages in cardiac replacement valves.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiovascular diseases (CVDs) is expected to drive the growth of the tissue heart valves market in the coming years. CVDs, which include conditions such as heart attacks, strokes, and hypertension, are among the leading causes of mortality worldwide. This rise is primarily driven by unhealthy lifestyles, aging populations, increased prevalence of risk factors, poor diets, physical inactivity, smoking, stress, and urbanization, all contributing to higher rates of heart-related disorders. Tissue heart valves play a crucial role in treating cardiovascular diseases by offering a biocompatible, durable, and less thrombogenic solution for patients requiring valve replacement, ultimately improving long-term heart function and reducing complications. For example, in September 2024, a report by the Heart Failure Society of America (HFSA) stated that approximately 6.7 million Americans aged 20 and older are living with heart failure (HF), with projections estimating this number to rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. This rising burden of CVDs is fueling the demand for tissue heart valves.

Companies operating in the tissue heart valves market are focusing on technological innovations to improve patient outcomes. For instance, in June 2024, Medtronic plc, an Ireland-based technology company, launched the Avalus Ultra valve, a next-generation surgical aortic tissue valve designed to enhance ease of use during implantation and support long-term patient management. This valve, built on a decade of clinical experience with the Avalus valve, features a low profile, a polyetheretherketone (PEEK) base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA) to improve blood flow. Additionally, it includes a radiopaque coil for better visibility in future valve-in-valve procedures, ensuring long-term durability for patients with aortic stenosis.

In February 2024, Foldax Inc., a US-based medical device company, partnered with Dolphin Life Science India LLP to manufacture the Tria polymer mitral surgical heart valve in India. This collaboration enables in-country production and distribution, making advanced heart valve solutions more accessible to patients. Dolphin Life Science India LLP is an India-based life sciences company specializing in heart valve manufacturing and distribution.

Major players in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomedica, On-X Life Technologies Inc., Anteris Technologies Ltd., Labcor Laboratorios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, Neovasc Inc.

North America was the largest region in the tissue heart valves market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tissue heart valves report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tissue heart valves market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue heart valves market consists of sales of porcine xenograft valves, bovine pericardial valves, and autograft valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Heart Valves Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue heart valves market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue heart valves ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue heart valves market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Stented Tissue Heart Valves; Stentless Tissue Heart Valves
2) By Valve Type: Aortic; Mitral; Tricuspid; Pulmonary
3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Stented Tissue Heart Valves: Bovine Pericardial Valves; Porcine Valves
2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves; Homograft Valves
Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Edwards Lifesciences Corporation; LivaNova PLC; Meril Life Sciences Pvt. Ltd.; MicroPort Scientific Corporation; LifeNet Health Inc.; TTK Healthcare Ltd.; Braile Biomedica; On-X Life Technologies Inc.; Anteris Technologies Ltd.; Labcor Laboratorios Ltd.; CARDION s.r.o.; CryoLife Inc.; Colibri Heart Valve LLC; Foldax Inc.; Balance Medical Technologies Co. Ltd.; MiCardia Corporation; Neovasc Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r34168u

1. Executive Summary

2. Tissue Heart Valves Market Characteristics

3. Tissue Heart Valves Market Trends And Strategies

4. Tissue Heart Valves Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tissue Heart Valves Growth Analysis And Strategic Analysis Framework

5.1. Global Tissue Heart Valves PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Tissue Heart Valves Market Growth Rate Analysis
5.4. Global Tissue Heart Valves Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Tissue Heart Valves Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Tissue Heart Valves Total Addressable Market (TAM)

6. Tissue Heart Valves Market Segmentation

6.1. Global Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stented Tissue Heart Valves
Stentless Tissue Heart Valves
6.2. Global Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Aortic
Mitral
Tricuspid
Pulmonary
6.3. Global Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Other End-Users
6.4. Global Tissue Heart Valves Market, Sub-Segmentation Of Stented Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bovine Pericardial Valves
Porcine Valves
6.5. Global Tissue Heart Valves Market, Sub-Segmentation Of Stentless Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bovine Pericardial Stentless Valves
Homograft Valves

7. Tissue Heart Valves Market Regional And Country Analysis

7.1. Global Tissue Heart Valves Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Tissue Heart Valves Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Heart Valves Market

8.1. Asia-Pacific Tissue Heart Valves Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Heart Valves Market

9.1. China Tissue Heart Valves Market Overview
9.2. China Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Heart Valves Market

10.1. India Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Heart Valves Market

11.1. Japan Tissue Heart Valves Market Overview
11.2. Japan Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Heart Valves Market

12.1. Australia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Heart Valves Market

13.1. Indonesia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Heart Valves Market

14.1. South Korea Tissue Heart Valves Market Overview
14.2. South Korea Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Heart Valves Market

15.1. Western Europe Tissue Heart Valves Market Overview
15.2. Western Europe Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Heart Valves Market

16.1. UK Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Heart Valves Market

17.1. Germany Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Heart Valves Market

18.1. France Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Heart Valves Market

19.1. Italy Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Heart Valves Market

20.1. Spain Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Heart Valves Market

21.1. Eastern Europe Tissue Heart Valves Market Overview
21.2. Eastern Europe Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Heart Valves Market

22.1. Russia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Heart Valves Market

23.1. North America Tissue Heart Valves Market Overview
23.2. North America Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Heart Valves Market

24.1. USA Tissue Heart Valves Market Overview
24.2. USA Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Heart Valves Market

25.1. Canada Tissue Heart Valves Market Overview
25.2. Canada Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Heart Valves Market

26.1. South America Tissue Heart Valves Market Overview
26.2. South America Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Heart Valves Market

27.1. Brazil Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Heart Valves Market

28.1. Middle East Tissue Heart Valves Market Overview
28.2. Middle East Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Heart Valves Market

29.1. Africa Tissue Heart Valves Market Overview
29.2. Africa Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Heart Valves Market Competitive Landscape And Company Profiles

30.1. Tissue Heart Valves Market Competitive Landscape
30.2. Tissue Heart Valves Market Company Profiles
- 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Heart Valves Market Other Major And Innovative Companies

31.1. Meril Life Sciences Pvt. Ltd.
31.2. MicroPort Scientific Corporation
31.3. LifeNet Health Inc.
31.4. TTK Healthcare Ltd.
31.5. Braile Biomedica
31.6. On-X Life Technologies Inc.
31.7. Anteris Technologies Ltd.
31.8. Labcor Laboratorios Ltd.
31.9. CARDION s.r.o.
31.10. CryoLife Inc.
31.11. Colibri Heart Valve LLC
31.12. Foldax Inc.
31.13. Balance Medical Technologies Co. Ltd.
31.14. MiCardia Corporation
31.15. Neovasc Inc.

32. Global Tissue Heart Valves Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Heart Valves Market

34. Recent Developments In The Tissue Heart Valves Market

35. Tissue Heart Valves Market High Potential Countries, Segments and Strategies

35.1 Tissue Heart Valves Market In 2029 - Countries Offering Most New Opportunities
35.2 Tissue Heart Valves Market In 2029 - Segments Offering Most New Opportunities
35.3 Tissue Heart Valves Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer